Evidence map›Paper›PMID 36009596›Full record

ArticleBiomedicines2022

Hashimoto's Thyroiditis Minimizes Lymph Node Metastasis in

Peter P Issa, Mahmoud Omar, Yusef Buti, Chad P Issa, Bert Chabot, Christopher J Carnabatu, Ruhul Munshi, Mohammad Hussein, Mohamed Aboueisha, Mohamed Shama and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Association of BRAFInternational journal of molecular sciences · 2022
    Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.Journal of cancer research and clinical oncology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Younger Than 55 Years Old andInternational journal of general medicine · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Peter P IssaSchool of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID 0000-0002-5248-3142
Mahmoud OmarDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Yusef ButiDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Chad P IssaSchool of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Bert ChabotDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Christopher J CarnabatuDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Ruhul MunshiDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Mohammad HusseinDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Mohamed AboueishaDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Mohamed ShamaDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Ralph L CorsettiDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Eman ToraihDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.ORCID 0000-0001-9267-3787
Emad KandilDepartment of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Tulane University · USLouisiana State University Health Sciences Center New Orleans · USSuez Canal University · EG

Funding

American Thyroid Association THYROIDGRANT2021-0000000232Tulane University Tulane University Bridge Fund
6 · The paper itself

Abstract

Hashimoto's thyroiditis (HT) (autoimmune thyroiditis) is a clinicopathological entity associated with chronic lymphocytic infiltration resulting in hypothyroidism. HT is a double-edged sword that increases the risk of papillary thyroid cancer (PTC), yet it serves as a protective factor for PTC progression.

Indexed as

Hashimoto’s thyroiditislymph node metastasisprotective factorrisk factorthyroid cancer

Identifiers

PMID36009596
PMCPMC9405831
OpenAlexW4292694399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.